<List><item><source>MED</source><extId>27454112</extId><pmcid>PMC5058631</pmcid><annotations><annotation><prefix>zed pertuzumab (pdb </prefix><exact>1S78</exact><postfix>) as a representativ</postfix><tags><tag><name>1S78</name><uri>http://identifiers.org/pdb/1S78</uri></tag></tags><id>http://europepmc.org/articles/PMC5058631#europepmc-56b464b3027e5e455c9b7092bae3394a</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>Fab and PGT128 (pdb </prefix><exact>3TV3</exact><postfix>) as a representativ</postfix><tags><tag><name>3TV3</name><uri>http://identifiers.org/pdb/3TV3</uri></tag></tags><id>http://europepmc.org/articles/PMC5058631#europepmc-01ff39ae8052f1a01df3173a2bae8ba9</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>riginated from pdbs </prefix><exact>1NL0</exact><postfix> (10C12 Fab) and 3TH</postfix><tags><tag><name>1NL0</name><uri>http://identifiers.org/pdb/1NL0</uri></tag></tags><id>http://europepmc.org/articles/PMC5058631#europepmc-b29c8a167b37805aaa8bc683e31b056f</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>NL0 (10C12 Fab) and </prefix><exact>3THM</exact><postfix> (EP6b_B01 Fab).25,2</postfix><tags><tag><name>3THM</name><uri>http://identifiers.org/pdb/3THM</uri></tag></tags><id>http://europepmc.org/articles/PMC5058631#europepmc-3d0978ef57095da4d6c61581da320467</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation></annotations></item></List>